What are Nitrosourea alkylating agent drugs?

Nitrosourea alkylating agent drugs are pharmacologic agents that share a common mechanism (typically targeting DNA (non-specific alkylating agent)). 0 are currently marketed, with 3 more in clinical development.

Nitrosourea alkylating agent

0 marketed 3 in Phase 3

This page covers all Nitrosourea alkylating agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting DNA (non-specific alkylating agent), DNA (non-selective alkylating agent).

Targets

DNA (non-specific alkylating agent) · DNA (non-selective alkylating agent)

Phase 3 pipeline (3)

Carmustine BCNU · Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie · Oncology
Carmustine is a nitrosourea alkylating agent that cross-links DNA strands, preventing cell replication and inducing cancer cell death.
CCNU · Radiation Therapy Oncology Group · Oncology
CCNU (lomustine) is a nitrosourea alkylating agent that cross-links DNA strands, preventing cell replication and inducing cancer cell death.
Lomustine Chemotherapy · AstraZeneca · Oncology
Lomustine is a nitrosourea alkylating agent that cross-links DNA strands, preventing cancer cell replication and inducing cell death.